Frontotemporal dementia: Implications for understanding Alzheimer disease

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 2, 2012, Pages

  Goedert, Michel ^a   Ghetti, Bernardino ^b   Spillantini, Maria Grazia ^c  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMATIN MODIFYING PROTEIN 2B; DNA BINDING PROTEIN; DNA BINDING PROTEIN 43; FUSED IN SARCOMA PROTEIN; PEPTIDES AND PROTEINS; PROGRANULIN; TAR DNA BINDING PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG; VALOSIN CONTAINING PROTEIN; ADENOSINE TRIPHOSPHATASE; C9ORF72 PROTEIN, HUMAN; CDC48 PROTEIN; CELL CYCLE PROTEIN; CHMP2A PROTEIN, HUMAN; ESCRT PROTEIN; FUS PROTEIN, XENOPUS; GRN PROTEIN, HUMAN; MAPT PROTEIN, HUMAN; PROTEIN; PROTEIN TDP-43; RNA BINDING PROTEIN; SIGNAL PEPTIDE; XENOPUS PROTEIN;

ALZHEIMER DISEASE; ARTICLE; AUTOSOME; BRAIN DISEASE; CHROMOSOME 17; CHROMOSOME 9 OPEN READING FRAME 72; CORTICOBASAL SYNDROME; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HISTOPATHOLOGY; HUMAN; MOTOR NEURON DISEASE; MULTIVESICULAR BODY; NERVE DEGENERATION; NEUROIMAGING; NONHUMAN; PARKINSONISM; PROGRESSIVE NONFLUENT APHASIA; PROGRESSIVE SUPRANUCLEAR PALSY; SEMANTIC DEMENTIA; GENETICS; HISTORY; METABOLISM; MUTATION; PERSONALITY DISORDER; REVIEW;

ADENOSINE TRIPHOSPHATASES; ALZHEIMER DISEASE; CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN, PAIR 17; DNA-BINDING PROTEINS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; FRONTOTEMPORAL DEMENTIA; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MOTOR NEURON DISEASE; MUTATION; PERSONALITY DISORDERS; PROTEINS; RNA-BINDING PROTEINS; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS; XENOPUS PROTEINS;

EID: 84864383087     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a006254     Document Type: Article

References (184)

1. Alladi S, Xuereb J, Bak T, Nestor P, Knibb J, Patterson K, Hodges JR. 2007. Focal cortical presentations of Alzheimer's disease. Brain 130: 2636-2645.
2. Alzheimer A. 1907. Über eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiat 64: 146-148.
3. Alzheimer A. 1911. Über eigenartige Krankheitsfälle des späteren Alters. Z ges Neurol Psychiat 4: 356-385.
4. Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW. 2007. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 61: 435-445.
5. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, TsuchiyaK, Yoshida M, Hashizume Y, et al. 2006. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351: 602-611.
6. Asuni AA, Boutajangout A, Quatermain D, Sigurdsson EM. 2007. Immunotherapy targeting pathological tau conformers in a transgenic mouse model reduces brain pathology associated with functional improvements. J Neurosci 27: 9115-9129.
7. Ayala YM, De Conti L, Avendano-Vázquez SE, Dhir A, Romano M, D'AmbrogioA, Tollervey J, Ule J, Baralle M, Buratti E, et al. 2011. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J 30: 277-288.
8. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, LindholmC, Snowden J, Adamson J, Sadovnick AD, Rollinson S, et al. 2006. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442: 916-919.
9. Benajiba L, Le Ber I, Camuzat A, Lacoste M, Thomas-Anterion C, Couratier P, Legallic S, Salachas F, Hannequin D, Decousus M, et al. 2009. TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol 65: 470-474.
10. Bonfiglio F. 1938. Die umschriebene Atrophie der Basalganglien. Z Neurol 160: 306-333.
11. Braak H, Del Tredici K. 2011. The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol 121: 171-181.
12. Brion JP, Passareiro H, Nunez J, Flament-Durand J. 1985. Mise en évidence immunologique de la protéine tau au niveau des lésions de dégénérescence neurofibrillaire de la maladie d'Alzheimer. Arch Biol 95: 229-235.
13. Broca P. 1861. Perte de la parole, ramollissement chronique et destruction partielle du lobe antérieur gauche du cerveau. Bull Soc Anthropol 2: 235-238.
14. Brun A. 1987. Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. Arch Gerontol Geriatr 6: 193-208.
15. Bugiani O, Murrell JR, Giaccone G, Hasegawa M, Ghigo G, Tabaton M, MorbinM, Primavera A, Carella F, Solaro C, et al. 1999. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in Tau. J Neuropathol Exp Neurol 58: 667-677.
16. Caffrey TM, Joachim C, Paracchini S, Esiri MM, Wade-Martins R. 2006. Haplotype-specific expression of exon 10 at the human MAPT locus. Hum Mol Genet 15: 3529-3537.
17. Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, Fraser G, Stalder AK, Beibel M, Staufenbiel M, et al. 2009. Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11: 909-913.
18. Colby DW, Prusiner SB. 2011. Prions. Cold Spring Harb Perspect Biol 3: a006833.
19. Constantinidis J, Richard J, Tissot R. 1974. Pick's disease. Histological and clinical correlations. Eur Neurol 11: 208-217.
20. Coomaraswamy J, Kilger E, Wölfing H, Schäfer C, Kaeser SA, Wegenast-BraunBM, Hefendehl JK, Wolburg H, Mazzella M, Ghiso J, et al. 2010. Modeling familial Danish dementia in mice supports the concept of the amyloid hypothesis of Alzheimer's disease. Proc Natl Acad Sci 107: 7969-7974.
21. Crowther RA, Goedert M. 2000. Abnormal tau-containing filaments in neurodegenerative diseases. J Struct Biol 130: 271-279.
22. Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, Rademakers R, Vandenberghe R, Dermaut B, Martin JJ, et al. 2006. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442: 920-924.
23. Cushman M, Johnson BS, King OD, Gitler AD, Shorter J. 2010. Prion-like disorders: Blurring the divide between transmissibility and infectivity. J Cell Sci 123: 1191-1201.
24. Custer SK, Neumann M, Lu H, Wright AC, Taylor JP. 2010. Transgenic mice expressing mutant forms of VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone. Hum Mol Genet 19: 1741-1755.
25. Déjerine J, Sérieux P. 1897. Un cas de surdité verbale pure terminée par aphasie sensorielle, suivi d'autopsie. CR Acad Sci Paris 49: 1074-1077.
26. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, RutherfordNJ, Nicholson AM, Finch NA, Flynn H, Adamson J, et al. 2011. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron doi: 10. 1016/j. neuron. 2011. 09. 011.
27. Dormann D, Rodde R, Edbauer D, Bentmann E, Fischer I, Hruscha A, Than ME, Mackenzie IRA, Capell A, Schmid B, et al. 2010. ALS-associated fused in sarcoma (FUS) mutations disrupt transportin-mediated nuclear import. EMBO J 29: 21841-21857.
28. Feany MB. 2010. New approaches to the pathology and genetics of neurodegeneration. Am J Pathol 176: 2058-2066.
29. Feany MB, Dickson DW. 1995. Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 146: 1388-1396.
30. Foster NL, Wilhelmsen K, Sima AA, Jones MZ, D'Amato CJ, Gilman S. 1997. Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference. Ann Neurol 41: 706-715.
31. Freud S. 1891. Zur Auffassung der Aphasien. Franz Deuticke, Leipzig und Wien.
32. Frost B, Jacks RL, Diamond MI. 2009. Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 284: 12845-12852.
33. Fu YJ, Nishihara Y, Kuroda S, Toyoshima Y, Ishihara T, Shinozaki M, MiyashitaA, Piao YS, Tan CF, Tani T, et al. 2010. Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: A distinct neuropathological and biochemical disease entity. Acta Neuropathol 120: 21-32.
34. Galantucci S, Tartaglia MC, Wilson SM, Henry ML, Filippi M, Agosta F, DronkersNF, Henry RG, Ogar JM, Miller BL, et al. 2011. White matter damage in primary progressive aphasias: A diffusion tensor tractography study. Brain 134: 3011-3029.
35. Galton CJ, Patterson K, Xuereb JH, Hodges JR. 2000. Atypical and typical presentations of Alzheimer's disease: A clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 123: 484-498.
36. Gans A. 1923. Betrachtungen über Art und Ausbreitung des krankhaften Prozesses in einem Fall von Pickscher Atrophie des Stirnhirns. Z Neurol 80: 10-28.
37. Ghetti B, Tagliavini F, Giaccone G, Bugiani O, Frangione B, Farlow MR, DlouhySR. 1994. Familial Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles. Mol Neurobiol 8: 41-48.
38. Ghetti B, Wszolek ZW, Boeve BF, Spina S, Goedert M. 2011. Frontotemporal dementia and parkinsonism linked to chromosome 17. In Neurodegeneration: The molecular pathology of dementia and movement disorders, 2nd ed. (ed. Dickson D, Weller RO), pp. 110-134. Blackwell, Oxford, UK.
39. Ghidoni R, Benussi L, Glionna M, Franzoni M, Binetti G. 2008. Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration. Neurology 71: 1235-1239.
40. Giordana MT, Piccinini M, Grifoni S, De Marco G, Vercellino M, Magistrello M, Pellerino A, Buccinna B, Lupino E, Rinaudo MT. 2010. TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosis. Brain Pathol 20: 351-360.
41. Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D, HatanpaaKJ, White CL, Bigio EH, Caselli R, et al. 2008. TDP-43 A315 mutation in familial motor neuron disease. Ann Neurol 63: 535-538.
42. Goedert M, Spillantini MG. 2006. A century of Alzheimer's disease. Science 314: 777-781.
43. Goedert M, Wischik CM, Crowther RA, Walker JE, Klug A. 1988. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci 85: 4051-4055.
44. Goedert M, Spillantini MG, Potier MC, Ulrich J, Crowther RA. 1989a. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: Differential expression of tau protein mRNAs in human brain. EMBO J 8: 393-399.
45. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA. 1989b. Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3: 519-526.
46. Goedert M, Spillantini MG, Cairns NJ, Crowther RA. 1992. Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms. Neuron 8: 159-168.
47. Goedert M, Jakes R, Crowther RA. 1999. Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments. FEBS Lett 450: 306-311.
48. Goedert M, Clavaguera F, Tolnay M. 2010. The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 33: 317-325.
49. Gorno-Tempini ML, Murray RC, Rankin KP, Weiner MW, Miller BL. 2004a. Clinical, cognitive and anatomical evolution from nonfluent progressive aphasia to corticobasal syndrome: a case report. Neurocase 10: 426-436.
50. Gorno-Tempini ML, Dronkers NF, Rankin KP, Ogar JM, Phengrasamy L, RosenHJ, Johnson JK, Weiner MW, Miller BL. 2004b. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 55: 335-346.
51. Gorno-Tempini ML, Brambati SM, Ginex V, Ogar J, Dronkers NF, Marcone A, Perani D, Garibotto V, Cappa SF, Miller BL. 2008. The logopenic/phonological variant of primary progressive aphasia. Neurology 71: 1227-1234.
52. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM, Rohrer JD, Black S, Boeve BF, et al. 2011. Classification of primary progressive aphasia and its variants. Neurology 76: 1006-1014.
53. Grossman M, Mickanin J, Onishi K, Hughes E, D'Esposito M, Ding XS, Alavi A, Reivich M. 1996. Progressive nonfluent aphasia: Language, cognitive, and PET mesasures contrasted with probable Alzheimer disease. J Cogn Neurosci 8: 135-154.
54. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. 1986. Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci 83: 4913-4917.
55. Grünthal E. 1930. Über ein Brüderpaar mit Pickscher Krankheit. Z Neurol 129: 350-375.
56. Gustafson L. 1987. Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis. Arch Gerontol Geriatr 6: 209-223.
57. Guthrie CR, Schellenberg GD, Kraemer BC. 2009. SUT-2 potentiates tau-induced neurotoxity in Caenorhabditis elegans. Hum Mol Genet 18: 1825-1838.
58. Gydesen S, Brown JM, Brun A, Chakrabarti L, Gade A, Johannsen P, Rossor M, Thusgaard T, Grove A, Yancopoulou D, et al. 2002. Chromosome 3 linked frontotemporal dementia (FTD-3). Neurology 59: 1585-1594.
59. Hasegawa M, Smith MJ, Goedert M. 1998. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett 437: 207-210.
60. Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, BeachTG, Buratti E, Baralle F, Morita M, et al. 2008. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 64: 60-70.
61. Hodges JR, Patterson K. 2007. Semantic dementia: A unique clinicopathological syndrome. Lancet Neurol 6: 1004-1014.
62. Höglinger GU, Melhem NM, Dickson D, Sleiman PMA, Wang LS, Klei L, Rademakers R, de Silva R, Litvan I, Riley DC, et al. 2011. Common variants affect risk for the tauopathy progressive supranuclear palsy. Nat Genet 43: 699-705.
63. Holm IE, Isaacs AM, Mackenzie IRA. 2009. Absence of FUS-immunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B gene. Acta Neuropathol 118: 719-720.
64. Hu F, Padukkavidana T, Vaegter CB, Brady OA, Zheng Y, Mackenzie IR, FeldmanHH, Nykjaer A, Strittmatter SM. 2010. Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin. Neuron 68: 654-667.
65. Hutton M, Lendon CL, Rizzu M, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, et al. 1998. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393: 702-705.
66. Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, Van Eersel J, Wölfing H, ChiengBC, Christie J, Napier IA, et al. 2010. Dendritic function of tau mediates amyloid-β toxicity in Alzheimer's disease mouse models. Cell 142: 387-397.
67. Johnson JK, Head E, Kim R, Starr A, Cotman CW. 1999. Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch Neurol 56: 1233-1239.
68. Johnson BS, Snead D, Lee JJ, McCaffery MM, Shorter J, Gitler AD. 2009. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and toxicity. J Biol Chem 284: 20329-20339.
69. Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, TrojanowskiJQ, Gibbs JR, Brunetti M, Gronka S, Wuu J, et al. 2010. Exome sequencing revealsVCP mutations as a cause of familial ALS. Neuron 68: 857-864.
70. Josephs KA, Dickson DW. 2007. Frontotemporal lobar degeneration with upper motor neuron disease/primary lateral sclerosis. Neurology 69: 1800-1801.
71. Josephs KA, Duffy JR, Strand EA, Whitwell JL, Layton KF, Parisi JE, Hauser MF, Witte RJ, Boeve BF, Knopman DS, et al. 2006. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 129: 1385-1398.
72. Josephs KA, Whitwell JL, Parisi JE, Petersen RC, Boeve BF, Jack CR, Dickson DW. 2010. Caudate atrophy on MRI is a characteristic feature of FTLD-FUS. Eur J Neurol 17: 969-975.
73. Ju JS, Weihl CC. 2010. Inclusion body myopathy, Paget's disease of the bone and frontotemporal dementia: A disorder of autophagy. Hum Mol Genet 19: R38-R45.
74. Kertesz A, Hudson L, Mackenzie IRA, Munoz DG. 1994. The pathology and nosology of primary progressive aphasia. Neurology 44: 2065-2072.
75. Kertesz A, Martinez-Lage P, Davidson W, Munoz DG. 2000. The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 55: 1368-1375.
76. Koolen DA, Vissers LELM, Pfundt R, de Leeuw N, Knight SJL, Regan R, Kooy RF, Reyniers E, Romano C, Fichera M, et al. 2006. A new chromosome 17q21. 31 microdeletion syndrome associated with a common inversion polymorphism. Nat Genet 38: 999-1001.
77. Kovacs GG, Majtenyi K, Spina S, Murrell JR, Gelpi E, Höftberger R, Fraser G, Crowther RA, Goedert M, Budka H, et al. 2008. White matter tauopathy with globular glial inclusions: A distinct sporadic frontotemporal lobar degeneration. J Neuropathol Exp Neurol 67: 963-975.
78. Kovacs GG, Murrell JR, Horvath S, Haraszti L, Majtenyi K, Molnar MJ, Budka H, Ghetti B, Spina S. 2009. TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov Disord 24: 1843-1847.
79. Kraemer BC, Zhang B, Leverenz JB, Thomas JH, Trojanowski JQ, SchellenbergGD. 2003. Neurodegeneration and defective neurotransmission in aCaenorhabditis elegans model of tauopathy. Proc Natl Acad Sci 100: 9980-9985.
80. Kwiatkowski TJ, Bosco DA, LeClerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, et al. 2009. Mutations in the FUS/TLSgene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323: 1205-1211.
81. Le Corre S, Klafki HW, Plesnila N, Hübinger G, Obermeier A, Sahagún H, MonseB, Seneci P, Lewis J, Eriksen J, et al. 2006. An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice. Proc Natl Acad Sci 103: 9673-9678.
82. Lee VMY, Balin BJ, Otvos L, Trojanowski JQ. 1991. A68-a major subunit of paired helical filaments and derivatized forms of normal tau. Science 251: 675-678.
83. Lee JA, Beigneux A, Tariq Ahmad S, Young SG, Gao FB. 2007. ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration. Curr Biol 17: 1561-1567.
84. Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, et al. 2001. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293: 1487-1491.
85. Lippa CF, Cohen R, Smith TW, Drachman DA. 1991. Primary progressive aphasia with focal neuronal achromasia. Neurology 41: 882-886.
86. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, GolbeLI, Grafman J, Growdon JH, et al. 1996. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 47: 1-9.
87. Lüers T, Spatz H. 1957. Picksche Krankheit. In Handbuch der speziellen Anatomie und Histologie (ed. Henke F, Lubarsch O), Vol. 13, pp. 614-715. Springer, Berlin.
88. Mackenzie IRA, Baborie A, Pickering-Brown S, Du Plessis D, Jaros E, Perry RH, Neary D, Snowden JS, Mann DMA. 2006. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration. Classification and relation to clinical phenotype. Acta Neuropathol 112: 539-549.
89. Mackenzie IRA, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, Perry RH, Trojanowski JQ, Mann DMA, Lee VMY. 2011. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122: 111-113.
90. Mesulam MM. 1982. Slowly progressive aphasia without generalized dementia. Ann Neurol 11: 592-598.
91. Mesulam MM. 1987. Primary progressive aphasia-differentiation from Alzheimer's disease. Ann Neurol 22: 533-534.
92. Mesulam MM. 2001. Primary progressive aphasia. Ann Neurol 49: 425-432.
93. Mesulam MM, Wicklund A, Johnson N, Rogalski E, Léger GC, Rademaker A, Weintraub S, Bigio EH. 2008. Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol 63: 709-719.
94. Meyer A. 1929. Über eine der amyotrophischen Lateralsklerose nahestehende Erkrankung mit psychischen Störungen. Z Neurol 121: 107-128.
95. Migliaccio R, Agosta F, Rascovsky K, Karydas A, Bonasera S, Rabinovici GD, Miller BL, Gorno-Tempini ML. 2009. Clinical syndromes associated with posterior atrophy. Neurology 73: 1571-1578.
96. Morita K, Kaiya H, Ikeda T, Namba M. 1987. Presenile dementia combined with amyotrophy: A review of 34 Japanese cases. Arch Gerontol Geriatr 6: 263-277.
97. Morris M, Maeda S, Vossel K, Mucke L. 2011. The many faces of tau. Neuron 70: 410-426.
98. Mummery CJ, Patterson K, Wise RJS, Vandenberghe R, Price CJ, Hodges JR. 1999. Disrupted temporal lobe connections in semantic dementia. Brain 122: 61-73.
99. Munoz DG, Neumann M, Kusaka H, Yokota O, Ishihara K, Terada S, Kuroda S, Mackenzie IR. 2009. FUS pathology in basophilic inclusion body disease. Acta Neuropathol 118: 617-627.
100. Murrell JR, Spillantini MG, Zolo P, Guazzelli M, Smith MJ, Hasegawa M, Redi F, Crowther RA, Pietrini P, Ghetti B, et al. 1999. Tau gene mutation G389R causes a tauopathy with abundant Pick body-like inclusions and axonal deposits. J Neuropathol Exp Neurol 58: 1207-1226.
101. Nacharaju P, Lewis J, Easson C, Yen S, Hackett J, Hutton M, Yen SH. 1999. Accelerated filament formation from tau protein with specific FTDP-17 mutations. FEBS Lett 447: 195-199.
102. Neary D, Snowden JS, Northen B, Goulding P. 1988. Dementia of frontal type. J Neurol Neurosurg Psychiatry 51: 353-361.
103. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, et al. 2003. Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula. Brain 126: 2406-2418.
104. Nestor PJ, Graham NL, Fryer TD, Williams GB, Patterson K, Hodges JR. 2003. Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula. Brain 126: 2406-2418.
105. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, et al. 2006. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130-133.
106. Neumann M, Mackenzie IR, Cairns NJ, Boyer PJ, Markesbery WR, Smith CD, Taylor JP, Kretzschmar HA, Kimonis VE, Forman MS. 2007. TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J Neuropathol Exp Neurol 66: 152-157.
107. Neumann M, Rademakers R, Roeber S, Baker M, Kretzschmar HA, MackenzieIRA. 2009a. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 132: 2922-2931.
108. Neumann A, Roeber S, Kretzschmar HA, Rademakers R, Baker M, MackenzieIRA. 2009b. Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol 118: 605-616.
109. Nishimoto Y, Ito D, Yagi T, Nihei Y, Tsunoda Y, Suzuki N. 2010. Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43. J Biol Chem 285: 608-619.
110. Okamoto K, Hirai S, Yamazaki T, Sun X, Nakazato Y. 1991. New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis. Neurosci Lett 129: 233-236.
111. Onari K, Spatz H. 1926. Anatomische Beiträge zur Lehre von der Pickschen umschriebenen Grosshirnrinden-Atrophie ("Picksche Krankheit"). Z Neurol 101: 470-511.
112. Pastor P, Ezquerra M, Munoz E, Marti MJ, Blesa R, Tolosa E, Oliva R. 2000. Significant association between the tau gene A0/A0 genotype and Parkinson's disease. Ann Neurol 47: 242-245.
113. Pick A. 1892. Ueber die Beziehungen der senilen Hirnatrophie zur Aphasie. Prager med Wschr 17: 165-167.
114. Pick A. 1901. Senile Hirnatrophie als Grundlage von Herderscheinungen. Wiener klin Wschr 14: 403-404.
115. Pick A. 1904. Zur Symptomatologie der linksseitigen Schläfenlappenatrophie. Mschr Psychiat Neurol 16: 378-388.
116. Pick A. 1906. Über einen weiteren Symptomencomplex im Rahmen der Dementia senilis, bedingt durch umschriebene stärkere Hirnatrophie (gemischte Apraxie). Mschr Psychiat Neurol 19: 97-108.
117. Pickhardt M, Gazova Z, von Bergen M, Khlistunova I, Wang Y, Hascher A, Mandelkow EM, Biernat J, Mandelkow E. 2005. Anthraquinones inhibit tau aggregation and dissolve Alzheimer paired helical filaments in vitro and in cells. J Biol Chem 280: 3628-3635.
118. Piguet O, Hornberger M, Mioshi E, Hodges JR. 2011a. Behavioural-variant frontotemporal dementia: Diagnosis, clinical staging, and management. Lancet Neurol 10: 162-172.
119. Piguet O, Halliday GW, Reid WGJ, Casey B, Carman R, Huang Y, Xuereb JH, Hodges JR, Kril JJ. 2011b. Clinical phenotypes in autopsy-confirmed Pick disease. Neurology 76: 253-259.
120. Pollock NJ, Mirra SS, Binder LI, Hansen LA, Wood JG. 1986. Filamentous aggregates in Pick's disease, progressive supranuclear palsy, and Alzheimer's disease share antigenic determinants with microtubule-associated protein, tau. Lancet 328: 1211.
121. Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, Ling SC, Sun E, Wancewicz E, Mazur C, et al. 2011. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci 14: 459-468.
122. Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, AndreadisA, Wiederholt WC, Raskind M, Schellenberg GD. 1998. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 43: 815-825.
123. Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC, O'Neil JP, Lal RA, Dronkers NF, Miller BL, et al. 2008. Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 64: 388-401.
124. Rebeiz JJ, Kolodny EM, Richardson EP. 1968. Corticodentonigral degeneration with neuronal achromasia. Arch Neurol 18: 20-33.
125. Reed LA, Grabowski TJ, Schmidt ML, Morris JC, Goate A, Solodkin A, Van Hoesen GW, Schelper RL, Talbot CJ, Wragg MA, et al. 1997. Autosomal dominant dementia with widespread neurofibrillary tangles. Ann Neurol 42: 564-572.
126. Renton AE, Majounie E, Waite A, Simón-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, Van Swieten JC, Myllykangas L, et al. 2011. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron doi: 10. 1016/j. neuron. 2011. 09. 010.
127. Richter H. 1918. Eine besondere Art von Stirnhirnschwund mit Verblödung. Z Neurol 38: 127-159.
128. Ritson GP, Custer SK, Freibaum BD, Guinto JB, Geffel D, Moore J, Tang W, Winton MJ, Neumann M, Trojanowski JQ, et al. 2010. TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97. J Neurosci 30: 7729-7739.
129. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, YuGQ, Mucke L. 2007. Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model. Science 316: 750-754.
130. Rossor MN, Fox NC, Mummery CM, Schott JM, Warren JD. 2010. The diagnosis of young-onset dementia. Lancet Neurol 9, 793-806.
131. Sampathu DM, Neumann M, Kwong LK, Chou TT, Micsenyi M, Truax A, Bruce J, Grossman M, Trojanowski JQ, Lee VMY. 2006. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am J Pathol 169: 1343-1352.
132. Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J. 2011. Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 470: 540-542.
133. Santacruz K, Lewis J, Spires T, Paulson J, KKKotilinek L, Ingelsson M, GuimaresA, DeTure M, Ramsden M, McGowan E, et al. 2005. Tau suppression in a neurodegenerative mouse model improves memory function. Science 309: 476-481.
134. Schmitt-John T, Drepper C, Mussmann A, Hahn P, Kuhlmann M, Thiel C, Hafner M, Lengeling A, Heimann P, Jones JM, et al. 2005. Mutation of Vps54causes motor neuron disease and defective spermiogenesis in the wobbler mouse. Nat Genet 37: 1213-1215.
135. Schneider C. 1927. Über Picksche Krankheit. Mschr Psychiat Neurol 65: 230-275.
136. Schneider C. 1929. Weitere Beiträge zur Lehre von der Pickschen Krankheit. Z Neurol 120: 340-384.
137. Seelaar H, Klijnsma KY, de Koning I, Van der Lugt A, Chiu WZ, Azmani A, Rozemuller AJM, Van Swieten JC. 2010. Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration. J Neurol 257: 747-753.
138. Sharp AJ, Hansen S, Selzer RR, Cheng Z, Regan R, Hurst JA, Stewart H, Price SM, Blair E, Hennekam RC, et al. 2006. Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome. Nat Genet 38: 1038-1042.
139. Shaw CE. 2010. Capturing VCP: Another molecular piece in the ALS jigsaw puzzle. Neuron 68: 812-814.
140. Shaw-Smith C, Pittman AM, Willatt L, Martin H, Rickman L, Gribble S, Curley R, Cumming S, Dunn C, Kalaitzopoulos D, et al. 2006. Microdeletion encompassingMAPT at chromosome 17q21. 3 is associated with developmental delay and learning disability. Nat Genet 38: 1032-1037.
141. Skibinski G, Parkinson NJ, Brown JM, Charkrabarti L, Lloyd SL, Hummerich H, Nielsen JE, Hodges JR, Spillantini MG, Thusgaard T, et al. 2005. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 37: 806-808.
142. Snowden JS, Goulding PJ, Neary D. 1989. Semantic dementia: A form of circumscribed atrophy. Behav Neurol 2: 167-182.
143. Spillantini MG, Crowther RA, Goedert M. 1996. Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles. Acta Neuropathol 92: 42-48.
144. Spillantini MG, Goedert M, Crowther RA, Murrell JR, Farlow MR, Ghetti B. 1997. Familial multiple system tauopathy with presenile dementia: A disease with abundant neuronal and glial tau filaments. Proc Natl Acad Sci 94: 4113-4118.
145. Spillantini MG, Bird TD, Ghetti B. 1998a. Frontotemporal dementia and parkinsonism linked to chromosome 17: A new group of tauopathies. Brain Pathol 8: 387-402.
146. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B. 1998b. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci 95: 7737-7741.
147. Spillantini MG, Crowther RA, Kamphorst W, Heutink P, Van Swieten JC. 1998c. Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau. Am J Pathol 153: 1359-1363.
148. Spina S, Murrell JR, Huey ED, Wassermann EM, Pietrini P, Grafman J, Ghetti B. 2007. Corticobasal syndrome associated with the A90D progranulin mutation. J Neuropathol Exp Neurol 66: 892-900.
149. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, DurnallJC, Williams KL, Buratti E, et al. 2008. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319: 1668-1672.
150. Stefansson H, Helgason A, Thorleifsson, Steintorsdottir V, Masson G, BarnardJ, Baker A, Jonasdottir A, Ingason A, Gudnadottir VG, et al. 2005. A common inversion under selection in Europeans. Nat Genet 37: 129-137.
151. Steele JC, Richardson JC, Olszewski J. 1964. Progressive supranuclear palsy. Arch Neurol 10: 333-359.
152. Stertz G. 1926. Über die Picksche Atrophie. Z Neurol 101: 729-749.
153. Strittmatter WJ, Roses AD. 1995. Apolipoprotein E and Alzheimer disease. Proc Natl Acad Sci 92: 4725-4727.
154. Sun Z, Diaz Z, Fang X, Hart MP, Chesi A, Shorter J, Gitler AD. 2011. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol 9: e1000614.
155. Tang W, Lu Y, Tian QY, Zhang Y, Guo FJ, Liu GY, Syed NM, Lai Y, Lin EA, KongL, et al. 2011. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 332: 478-484.
156. Taniguchi S, Suzuki N, Masuda M, Hisanaga SI, Iwatsubo T, Goedert M, Hasegawa M. 2005. Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols and porphyrins. J Biol Chem 280: 7614-7623.
157. Ticozzi N, Silani V, LeClerc AL, Keagle P, Gellera C, Ratti A, Taroni F, Kwiatkowski TJ, McKenna-Yasek DN, Sapp PC, et al. 2009. Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort. Neurology 73: 1180-1185.
158. Tollervey JR, Curk T, Rogelj B, Riese M, Cereda M, Kayikci M, König J, Hortobágyi T, Nishimura AL, Zupunski V, et al. 2011. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci 14: 452-458.
159. Vance C, Al-Chalabi A, Ruddy D, Smith BN, Hu X, Sreedharan J, Siddique T, Schelhaas HJ, Kusters B, Troost D, et al. 2006. Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13. p2-21. 3. Brain 129: 868-876.
160. Vance C, Rogelj B, Hortobágyi T, De Vos KJ, Nihimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P, et al. 2009. Mutations in FUS, an RNA processing protein, cause familial amyotrophic sclerosis type 6. Science 323: 1208-1211.
161. Van Deerlin VM, Sleiman PMA, Martinez-Lage M, Chen-Plotkin A, Wang LS, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Grossman M, et al. 2010. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet 42: 234-239.
162. Van der Flier WM, Pijnenburg YAL, Fox NC, Scheltens P. 2011. Early-onset versus late-onset Alzheimer's disease: The case of the missing APOE ε4 allele. Lancet Neurol 10: 280-288.
163. Van Mansvelt J. 1954. Pick's disease. MJvd Loeff, Enschede.
164. Van Swieten JC, Heutink P. 2008. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia. Lancet Neurol 7: 965-974.
165. Verhaart WJC. 1930. Over de ziekte van Pick. Nederl Tijdschr Geneesk 74: 5586-5598.
166. Vidal R, Delisle MB, Ghetti B. 2004. Neurodegeneration caused by proteins with an aberrant carboxyl-terminus. J Neuropathol Exp Neurol 63: 787-800.
167. Von Braunmühl A. 1932. Picksche Krankheit und amyotrophische Lateralsklerose. Allg Z Psychiat 96: 364-366.
168. Von Braunmühl A, Leonhard K. 1934. Über ein Schwesternpaar mit Pickscher Krankheit. Z Neurol 150: 209-241.
169. Watts GDJ, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, Pestronk A, Whyte MP, Kimonis VE. 2004. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36: 377-381.
170. Wernicke C. 1874. Der aphasische Symptomencomplex: Eine psychologische Studie auf anatomischer Basis. Max Cohn & Weigert, Breslau.
171. Wetzel MK, Naska S, Laliberte CL, Rymar VV, Fujitani M, Biernaskie JA, Cole CJ, Lerch JP, Spring S, Wang SH, et al. 2008. p73 regulates neurodegeneration and phospho-tau accumulation in aging and Alzheimer's disease. Neuron 59: 708-721.
172. Whitwell JL, Jack CR, Senjem ML, Josephs KA. 2006. Patterns of atrophy in pathologically confirmed FTLD with and without motor neuron degeneration. Neurology 66: 102-104.
173. Whitwell JL, Przybelski SA, Weigand SD, Ivnik RJ, Vemuri P, Gunter JL, SenjemML, Shiung MM, Boeve BF, Knopman DS, et al. 2009a. Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: A cluster analysis study. Brain 132: 2932-2946.
174. Whitwell JL, Jack CR, Boeve BF, Senjem ML, Baker M, Rademakers R, Ivnik RJ, Knopman DS, Wszolek ZK, Petersen RC, et al. 2009b. Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN. Neurology 72: 813-820.
175. Whitwell JL, Avula R, Senjem ML, Kantarci K, Weigand SD, Samikoglu A, Edmonson HA, Vemuri P, Knopman DS, Boeve BF, et al. 2010a. Gray and white matter water diffusion in the syndromic variants of frontotemporal dementia. Neurology 74: 1279-1287.
176. Whitwell JL, Jack CR, Boeve BF, Parisi JE, Ahlskog JE, Drubach DA, Senjem ML, Knopman DS, Petersen RC, Dickson DW, et al. 2010b. Imaging correlates of pathology in corticobasal syndrome. Neurology 75: 1879-1887.
177. Wilhelmsen KC, Lynch T, Pavlou E, Higgins M, Nygaard TG. 1994. Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am J Hum Genet 55: 1159-1164.
178. Williams DR, Lees AJ. 2009. Progressive supranuclear palsy: Clinicopathological concepts and diagnostic challenges. Lancet Neurol 8: 270-279.
179. Williams DR, Holton JL, Strand C, Pittman A, de Silva R, Lees AJ, Revesz T. 2007. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. Brain 130: 1566-1576.
180. Wischik CM, Novak M, Thogersen HC, Edwards PC, Runswick MJ, Jakes R, Walker JE, Milstein C, Roth M, Klug A. 1988. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci 85: 4506-4510.
181. Wittmann CW, Wszolek ZF, Shulman JM, Salvaterra PM, Lewis J, Hutton M, Feany MB. 2001. Tauopathy in Drosophila: Neurodegeneration without neurofibrillary tangles. Science 293: 711-714.
182. Yokoseki A, Shiga A, Tan CF, Tagawa A, Kaneko H, Koyama A, Eguchi H, Tsujino A, Ikeuchi T, Kakita A, et al. 2008. TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann Neurol 63: 538-542.
183. Yu CE, Bird TD, Bekris LM, Montine TJ, Leverenz JB, Steinbart E, Galloway NM, Feldman H, Woltjer R, Miller CA, et al. 2010. The spectrum of mutations in progranulin. Arch Neurol 67: 161-170.
184. Zhou J, Greicius MD, Gennatas ED, Growdon ME, Jang JY, Rabinovici GD, Kramer JH, Weiner M, Miller BL, Seeley WW. 2010. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. Brain 133: 1352-1367.